Postdoctoral Position Available in Braddock Lab
The Yale School of Medicine, Department of Pathology, is seeking a highly motivated postdoctoral associate to work in the Braddock lab, which investigates severe unmet medical illness through the study of Rare Diseases with a focus on dysregulated mineralization of the vasculature and the skeleton.
A Newfound Place of Pride for Pathology Labs
Scientists at Yale’s Molecular Diagnostics Lab, part of the Department of Pathology, rose to the challenge of the COVID-19 pandemic. In March 2020, the pathologists had none of the equipment or space necessary and far too few technicians qualified to process COVID-19 tests. By December 2020, they had the capacity to run an estimated 1,200 tests a day. Over the course of the pandemic, the Molecular Diagnostics Lab evolved from manually processing nasopharyngeal swabs to playing a crucial role in the validation and execution of Yale’s own FDA-approved SalivaDirect test.
Yale Scientists Reveal Molecular Pathway for Smarter Breast Cancer Drugs
New research at Yale has revealed major differences in aggressive types of breast cancer, and the potential for smarter treatments for patients. Triple-negative breast cancer, which has a low survival rate and a lack of helpful molecular biomarkers — specific proteins that signal the presence of disease — is among the most aggressive breast cancer subtypes.Source: Yale West Campus News
Lakshmanan Krishnamurti Named Chief of Pediatric Hematology, Oncology, and Bone Marrow Transplant at Yale New Haven Children’s Hospital and Smilow Cancer Hospital
Lakshmanan Krishnamurti, MD, has been named Chief of Pediatric Hematology, Oncology, and Bone Marrow Transplant at Yale New Haven Children’s Hospital and Leader of the Smilow Cancer Hospital Pediatric Hematology/Oncology Program.
The Understanding of Immunotherapy Biomarkers is Rapidly Evolving in Oncology
The landscape of immunotherapy biomarkers is rapidly evolving, and future developments are likely to have an impact on patients and clinicians alike, said Kurt A. Schalper, MD, PhD, in a virtual presentation during the 5th Annual International Congress on Oncology and Pathology.Source: OncLive
Mice with Human Blood: A New Way to Study Blood Disorders
Researchers from the Yale Department of Immunology and Yale Cancer Center have recently developed a mouse model that displays enhanced human erythropoiesis and mature RBC survival to help them better study human blood disorders.Source: Yale Scientific
Faculty Entrepreneurs Receive Research Support from Blavatnik Fund for Innovation at Yale
The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of applied research and technology in the life sciences.
Markers in blood predict severe COVID-19 infection
When attempting to predict who will end up in the ICU with COVID-19, the answer flows in the blood. Until now, there was no definitive way to chart a patient’s course, but there are known risk factors, like obesity, high blood pressure and diabetes.Source: WGNTV